Real world hypoglycaemia related to glucose variability and Flash glucose scan frequency assessed from global FreeStyle Libre data. Issue 11 (7th July 2022)

• Record Type: Journal Article
• Authors: Riveline, Jean‐Pierre; Wojtusciszyn, Anne; Guerci, Bruno; Alves, Clara; Kao, Kalvin; Xu, Yongjin; Dunn, Timothy C.
• Is Part Of: Diabetes, obesity & metabolism. Volume 24:Issue 11(2022)
• Page Start: 2102
• Page End: 2107
• Publication Date: 2022-07-07
• Subjects: blood glucose monitoring -- diabetes -- FreeStyle Libre -- glucose variability -- real life data; Diabetes -- Periodicals; Obesity -- Periodicals; Metabolism -- Disorders -- Periodicals; Clinical pharmacology -- Periodicals; 616.462
• DOI: 10.1111/dom.14795
• Languages: English
• ISSNs: 1462-8902

Abstract

Abstract: Aim: Flash glucose monitoring provides a range of glucose metrics. In the current study, we aim to identify those that indicate that glycaemic targets can be consistently met and contrast the total (t‐CV) and within‐day coefficient of variation (wd‐CV) to guide the assessment of glucose variability and hypoglycaemia exposure. Methods: De‐identified data from Flash readers were collected. The readers were sorted into 10 equally sized groups of scan frequency followed by quartiles of estimated A1c (eA1c). A similar grouping was performed for the total coefficient of variation (t‐CV) and within‐day coefficient of variation (wd‐CV). In addition, analysis of the association of time below 54 mg/dl and glucose variability measured by t‐CV and wd‐CV was performed. Results: The dataset included 1 002 946 readers. Readers sorted by 10 equal groups of scan rate and quartiles by eA1c, t‐CV and wd‐CV represented 25 074 readers per group. The association of lower eA1c with higher time in range and reduced time above range was clear. The correlation of eA1c quartiles and time below range was not consistent. An association between glucose variability and hypoglycaemia was found. Both wd‐CV and t‐CV were associated with time below range. For achieving the consensus target of <1% time below 54 mg/dl, the associated wd‐CV and t‐CV values were 33.5% and 39.5%, respectively. Conclusions: The type of CV reported by the different continuous glucose monitoring systems should be acknowledged. CV <36% might not be adequate to ensure low hypoglycaemia exposure. To our knowledge, the majority of continuous glucose monitoring reports the t‐CV. Appropriate thresholds should be used to identify patients that would probably meet time below range targets (t‐CV <40% or wd‐CV <34%).